<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>THIAMINE HYDROCHLORIDE
								Â - thiamine hydrochlorideÂ injection, solutionÂ </strong><br>General Injectables &amp; Vaccines, Inc<br></p></div>
<h1>Thiamine HCL 100 mg/mL Injection, USP 2 mL Multi Dose Vial</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>Description</h1>
<p class="First">Thiamine Hydrochloride Injection, USP is a sterile solution of thiamine hydrochloride in Water for Injection for intramuscular (IM) or slow intravenous (IV) administration.</p>
<p>Each mL contains: Thiamine hydrochloride 100 mg; chlororbutanol anhydrous (chloral derivative) 0.5%; monothioglycerol 0.5%; Water for Injection q.s.Â  Sodium hydroxide may have been added for pH adjustment (2.5 to 4.5).</p>
<p>Thiamine hydrochloride, or vitamin B1, occurs as white crystals or crystalline powder thatÂ  usually has a slight characteristic odor.Â  Freely soluble in water; soluble in glycerin; slightly soluble in alcohol; insoluble in ether and benzene.Â  Thiamine is rapidly destroyed in neutral or alkaline solutions but is stable in the dry state.Â  It is reasonably stable to heat in acid solution.</p>
<p>The chemical name of thiamine hydrochloride is thiazolium, 3-[(4-amino-2-methyl-5-pyrimidinyl)mythyl]-5-(2-hydroxyethyl)-4-methyl-chloride, monohydrochloride and it has the following structural formula:</p>
<div class="Figure"><img alt="Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4a8ea036-44e8-4329-ae13-3ef4ada26dfc&amp;name=Formula1.jpg"></div>
<p></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>Clinical Pharmacology</h1>
<p class="First"> The water soluble vitamins are widely distributed in both plants and animals. 
They are absorbed in man by both diffusion and active transport mechanisms. 
These vitamins are structurally diverse (derivatives of sugar, pyridine, 
purines, pyrimidine, organic acid complexes and nucleotide complex) and act as 
coenzymes, as oxidation-reduction agents, possibly as mitochondrial agents. 
Metabolism is rapid, and the excess is excreted in the urine. <br></p>
<p>Thiamine is 
distributed in all tissues. The highest concentrations occur in liver, brain, 
kidney and heart. When thiamine intake is greatly in excess of need, tissue 
stores increase two to three times. If intake is insufficient, tissues become 
depleted of their vitamin content. Absorption of thiamine following IM 
administration is rapid and complete. <br></p>
<p>Thiamine combines with adenosine 
triphosphate (ATP) to form thiamine pyrophosphate, also known as cocarboxylase, 
a coenzyme. Its role in carbohydrate metabolism is the decarboxylation of 
pyruvic acid in the blood and -ketoacids to acetaldehyde and <span class="product-label-link" type="condition" conceptid="4135927" conceptname="Carbon dioxide">carbon dioxide</span>. 
Increased levels of pyruvic acid in the blood indicate vitamin B1 deficiency. <br></p>
<p>The requirement for thiamine is greater when the carbohydrate content of the 
diet is raised. Body depletion of vitamin B1 can occur after approximately three 
weeks of total absence of thiamine in the diet.<br></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>Indications and Usage</h1>
<p class="First">Thiamine hydrochloride injection is effective for the treatment of thiamine 
deficiency or <span class="product-label-link" type="condition" conceptid="434620" conceptname="Beriberi">beriberi</span> whether of the dry (major symptoms related to the nervous 
system) or wet (major symptoms related to the cardiovascular system) variety. 
Thiamine hydrochloride injection should be used where rapid restoration of 
thiamine is necessary, as in Wernickeâ€™s <span class="product-label-link" type="condition" conceptid="372887" conceptname="Disorder of brain">encephalopathy</span>, infantile <span class="product-label-link" type="condition" conceptid="434620" conceptname="Beriberi">beriberi</span> with 
acute collapse, cardiovascular disease due to thiamine deficiency, or <span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span> 
of pregnancy if <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> is severe. It is also indicated when giving IV dextrose 
to individuals with marginal thiamine status to avoid precipitation of heart 
failure. <br></p>
<p>Thiamine hydrochloride injection is also indicated in patients with 
established thiamine deficiency who cannot take thiamine orally due to 
coexisting severe <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, or <span class="product-label-link" type="condition" conceptid="194993" conceptname="Intestinal malabsorption">malabsorption</span>. Thiamine 
hydrochloride injection is not usually indicated for conditions of decreased 
oral intake or decreased gastrointestinal absorption, because multiple vitamins 
should usually be given</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>Contraindications</h1>
<br>A history of sensitivity to thiamine or to any of the ingredients in this drug is a contraindication.Â  (See WARNINGS for further information.)<br>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>Warnings</h1>
<p class="First">WARNING: This product contains aluminum that may be toxic. Aluminum may reach 
toxic levels with prolonged parenteral administration if kidney function is 
impaired. Premature neonates are particularly at risk because their kidneys are 
immature, and they require large amounts of calcium and phosphate solutions, 
which contain aluminum. <br></p>
<p>Research indicates that patients with impaired kidney 
function, including premature neonates, who receive parenteral levels of 
aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels 
associated with central nervous system and bone toxicity. Tissue loading may 
occur at even lower rates of administration. <br></p>
<p>Serious 
<span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>/<span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span> can occur, especially after repeated 
administration. <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">Deaths</span> have resulted from IV or IM administration of thiamine 
(see package insert for ADVERSE REACTIONS). <br></p>
<p>Routine testing for 
<span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, in many cases, may not detect <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>. Nevertheless, 
a skin test should be performed on patients who are suspected of drug allergies 
or previous reactions to thiamine, and any positive responders should not 
receive thiamine by injection. <br></p>
<p>If <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to thiamine is suspected 
(based on history of <span class="product-label-link" type="condition" conceptid="439224" conceptname="Drug allergy">drug allergy</span> or occurrence of adverse reactions after 
thiamine administration), administer one-hundredth of the dose intradermally and 
observe for 30 minutes. If no reaction occurs, full dose can be given; the 
patient should be observed for at least 30 minutes after injection. Be prepared 
to treat <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span> regardless of the precautions taken. <br></p>
<p>Treatment 
of <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span> includes maintaining a patent airway and the use of 
epinephrine, oxygen, vasopressors, steroids and antihistamines.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>Precautions</h1>
<p class="First"><span class="Bold">General</span><br>Simple vitamin B1 deficiency is rare.Â  Multiple vitamin deficiencies should be suspected in any case of dietary inadequacy.</p>
<p><span class="Bold">Information for Patients</span><br>The patient should be advised as to proper dietary habits during treatment so that relapses will be less likely to occur with reduction in dosage or cessation of injection therapy.Â  <br></p>
<p><span class="Bold">Usage in Pregnancy</span><br>Pregnancy Category A- Studies in pregnant women have not shown that thiamine hydrochloride increases the risk of fetal abnormalities if administered during pregnancy.Â  If the drug is sued during pregnancy, the possibility of fetal harm appears remote.Â  Because studies cannot rule out the possibility of harm however, thiamine hydrochloride should be used during pregnancy only if clearly needed.Â  <br></p>
<p><span class="Bold">Nursing Mothers</span><br>It is not known whether this drug is excreted in human milk.Â  Because many drugs are excreted in human milk, caution should be exercised when thiamine hydrochloride is administered to a nursing mother.Â  <br></p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<h1>Adverse Reactions</h1>
<p class="First">An occasional individual may develop a <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> or life-threatening <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reaction</span> to thiamine, especially after repeatedÂ  injection.Â  collapse and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> have been reported.Â  A <span class="product-label-link" type="condition" conceptid="4141161" conceptname="Hot">feeling of warmth</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, tightness of the throat, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioneurotic edema</span>, <span class="product-label-link" type="condition" conceptid="438555" conceptname="Cyanosis">cyanosis</span>, <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>, and <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span> into the gastrointestinal tract have also been reported.Â  Some <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">tenderness</span> and <span class="product-label-link" type="condition" conceptid="4165876" conceptname="Induration">induration</span> may follow IM use (see WARNINGS).<br></p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-8"></a><p></p>
<h1>Overdosage</h1>
<p class="First">Parenteral doses of 100 to 500 mg singly have been administered without toxic effects.Â  However, dosages exceeding 30 mg three times a day are not utilized effectively.Â  <br></p>
<p>When the body tissues are saturated with thiamine, it is excreted in the urine as pyrimidine.Â  As the intake of thiamine is further increased, it appears unchanged in the urine.Â  <br></p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1>Dosage and Administration</h1>
<p class="First">Â â€œWetâ€? <span class="product-label-link" type="condition" conceptid="434620" conceptname="Beriberi">beriberi</span> with myocardial failure must be treated as an emergency cardiac 
condition, and thiamine must be administered slowly by the IV route in this 
situation (see WARNINGS). <br></p>
<p>In the treatment of <span class="product-label-link" type="condition" conceptid="434620" conceptname="Beriberi">beriberi</span>, 10 to 20 mg of thiamine 
hydrochloride are given IM three times daily for as long as two weeks. (See 
WARNINGS regarding repeated injection of thiamine.) An oral therapeutic 
multivitamin preparation containing 5 to 10 mg thiamine, administered daily for 
one month, is recommended to achieve body tissue saturation. <br></p>
<p>Infantile <span class="product-label-link" type="condition" conceptid="434620" conceptname="Beriberi">beriberi</span> 
that is mild may respond to oral therapy, but if collapse occurs, doses of 25 mg 
may cautiously be given IV. <br></p>
<p>Poor dietary habits should be corrected and an 
abundant and well-balanced dietary intake should be prescribed. <br></p>
<p>Patients with 
<span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span> of pregnancy in whom <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> is severe enough to preclude adequate 
oral therapy should receive 5 to 10 mg of thiamine hydrochloride IM daily. <br></p>
<p>In 
the treatment of Wernicke-Korsakoff syndrome, thiamine hydrochloride has been 
administered IV in an initial dose of 100 mg, followed by IM doses of 50 to 100 
mg daily until the patient is consuming a regular, balanced diet. (See WARNINGS 
regarding repeated injections of thiamine.) <br></p>
<p>Patients with marginal thiamine 
status to whom dextrose is being administered should receive 100 mg thiamine 
hydrochloride in each of the first few liters of IV fluid to avoid precipitating 
<span class="product-label-link" type="condition" conceptid="316139" conceptname="Heart failure">heart failure</span>. <br></p>
<p>Parenteral drug products should be inspected visually for 
particulate matter and discoloration prior to administration, whenever solution 
and container permit.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1>How Supplied</h1>
<a name="i20e0a8b7-f76e-44b8-8cc7-c631c7f676fc"></a><table border="1" width="710"><tbody class="Headless">
<tr class="First">
<td><span class="Bold">Product No.</span></td>
<td><span class="Bold">NDC No.</span></td>
<td><span class="Bold">Thiamine HCL/mL</span></td>
<td><span class="Bold">Volume</span></td>
</tr>
<tr class="Last">
<td>1302<br>
</td>
<td>63323-013-02<br>
</td>
<td>100 mg<br>
</td>
<td>2 mL<br>
</td>
</tr>
</tbody></table>2 mL size is a multiple dose vial, packaged 25 vials per tray. Store at 20Â° to 
25Â°C (68Â° to 77Â°F)Â  [see USP Controlled Room Temperature]. <br><span class="Bold">PROTECT FROM 
LIGHT.</span><br>Use only if solution is clear and seal intact.<br><br>APP<br>APP Pharmaceuticals, LLC<br>Schaumburg, IL 60173<br><br>45819E<br>Revised: May 2008<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<h1>Sample Outer Label</h1>
<p class="First"><img alt="Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4a8ea036-44e8-4329-ae13-3ef4ada26dfc&amp;name=Label1.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>THIAMINE HYDROCHLORIDE
								Â 		
					</strong><br><span class="contentTableReg">thiamine hydrochloride injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:52584-005(NDC:63323-013)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAMUSCULAR, INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Thiamine Hydrochloride</strong> (Thiamine) </td>
<td class="formItem">Thiamine Hydrochloride</td>
<td class="formItem">100Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:52584-005-02</td>
<td class="formItem">1  in 1 BAG</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">2 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA080556</td>
<td class="formItem">09/01/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>General Injectables &amp; Vaccines, Inc
							(108250663)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 1/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>67758ee3-1c83-4cc3-9e64-2c5e8617b264</div>
<div>Set id: 4a8ea036-44e8-4329-ae13-3ef4ada26dfc</div>
<div>Version: 2</div>
<div>Effective Time: 20120123</div>
</div>
</div>Â <div class="DistributorName">General Injectables &amp; Vaccines, Inc</div></p>
</body></html>
